Desloratadine
Desloratadine is a once-daily antihistamine used to relieve seasonal and year-round allergic rhinitis (nasal allergy) symptoms and to treat chronic idiopathic urticaria (long-lasting hives with no known cause).
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 14 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Desloratadine (Clarinex) is a once-daily antihistamine for seasonal and year-round nasal allergies (allergic rhinitis) and chronic hives with no known cause, blocking histamine, the body's allergy signal; it is the active form of loratadine (Claritin), on the U.S. market since about 2001 and available as a generic. Most people tolerate it well and usually notice little beyond dry mouth, a sore throat, tiredness or headache, with less drowsiness than older antihistamines. Stop it and get help right away for signs of a serious allergic reaction, such as swelling or trouble breathing. With liver or kidney problems, tell your prescriber, since you may need to take it less often.
Clinical pearls
- If loratadine (Claritin) ever gave you an allergic reaction, avoid desloratadine too, since it is loratadine's active form.
- Food and grapefruit juice do not change how much you absorb, so take it whenever in the day is easiest to remember.
- The orally disintegrating tablet (Clarinex Reditabs) dissolves on the tongue, a handy option for anyone who struggles to swallow tablets.
- Desloratadine needs a prescription, but its close relative loratadine is sold over the counter, often for less.
Patient information guide A plain-language walkthrough of Desloratadine, written from its FDA label.
What Desloratadine is used for
▾
Desloratadine treats allergy-related conditions. Supported uses include:
- Seasonal allergic rhinitis: relief of nasal and non-nasal symptoms (age 2 and older for Clarinex, desloratadine oral solution and desloratadine orally disintegrating tablets; age 12 and older for Desloratadine Tablets).
- Perennial allergic rhinitis: relief of nasal and non-nasal symptoms (age 6 months and older for Clarinex, oral solution and orally disintegrating tablets; age 12 and older for Desloratadine Tablets).
- Chronic idiopathic urticaria: relief of itching and fewer, smaller hives (age 6 months and older for Clarinex, oral solution and orally disintegrating tablets; age 12 and older for Desloratadine Tablets).
How Desloratadine works
▾
Desloratadine is a long-acting antihistamine that selectively blocks histamine H1 receptors. Histamine drives allergy symptoms such as sneezing, runny nose, itching and hives. Blocking its receptor reduces those symptoms.
In lab studies, desloratadine also reduced histamine release from human mast cells. Animal studies suggested it does not readily cross the blood-brain barrier, though the clinical significance is unknown.
Desloratadine dosage
▾
Desloratadine is taken by mouth once a day, with or without food. Products differ in form and age range.
- Tablets: swallowed once daily.
- Orally disintegrating tablets: placed on the tongue to dissolve, with or without water, taken right after opening the blister.
- Oral solution: measured with a dropper or syringe; the amount depends on age.
Adults with liver or kidney impairment may be started on a less frequent schedule. Follow your prescriber and the product label.
Dosing details from the FDA-approved label
From the Desloratadine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Adults and Adolescents 12 Years of Age and Over
- Tablets or RediTabs/orally disintegrating tablets: one 5 mg tablet once daily
- Oral Solution: 2 teaspoonfuls (5 mg in 10 mL) once daily
- May be taken without regard to meals
- Children 6 to 11 Years of Age
- Oral Solution: 1 teaspoonful (2.5 mg in 5 mL) once daily
- RediTabs/orally disintegrating tablets: one 2.5 mg tablet once daily
- May be taken without regard to meals
- Children 12 Months to 5 Years of Age
- Oral Solution: ½ teaspoonful (1.25 mg in 2.5 mL) once daily
- Orally disintegrating tablets are not recommended under 6 years of age
- Children 6 to 11 Months of Age
- Oral Solution: 2 mL (1 mg) once daily
- Adults with Hepatic or Renal Impairment
- Starting dose of one 5 mg tablet every other day
- Based on pharmacokinetic data; dosing recommendation for children with liver or renal impairment cannot be made due to lack of data
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Although the oral solution and the orally disintegrating tablet formulation of desloratadine may be available in the marketplace, CLARINEX ® Oral Solution and CLARINEX ® RediTabs ® Tablets are no longer marketed. CLARINEX Tablets, Oral Solution, or RediTabs Tablets may be taken without regard to meals. Place CLARINEX (desloratadine) RediTabs Tablets on the tongue and allow to disintegrate before swallowing. Tablet disintegration occurs rapidly. Administer with or without water. Take tablet immediately after opening the blister. The age-appropriate dose of CLARINEX Oral Solution should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (½ teaspoon) . Dosage (by age): Adults and Adolescents 12 Years of Age and Over: CLARINEX Tablets - one 5 mg tablet once daily or CLARINEX RediTabs Tablets - one 5 mg tablet once daily or CLARINEX Oral Solution - 2 teaspoonfuls (5 mg in 10 mL) once daily ( 2 ) Children 6 to 11 Years of Age: CLARINEX Oral Solution - 1 teaspoonful (2.5 mg in 5 mL) once daily or CLARINEX RediTabs Tablets - one 2.5 mg tablet once daily ( 2 ) Children 12 Months to 5 Years of Age: CLARINEX Oral Solution - ½ teaspoonful (1.25 mg in 2.5 mL) once daily ( 2 ) Children 6 to 11 Months of Age: CLARINEX Oral Solution - 2 mL (1 mg) once daily ( 2 ) 2.1 Adults and Adolescents 12 Years of Age and Over The recommended dose of CLARINEX Tablets or CLARINEX RediTabs Tablets is one 5-mg tablet once daily. The recommended dose of CLARINEX Oral Solution is 2 teaspoonfuls (5 mg in 10 mL) once daily. 2.2 Children 6 to 11 Years of Age The recommended dose of CLARINEX Oral Solution is 1 teaspoonful (2.5 mg in 5 mL) once daily. The recommended dose of CLARINEX RediTabs Tablets is one 2.5-mg tablet once daily. 2.3 Children 12 Months to 5 Years of Age The recommended dose of CLARINEX Oral Solution is ½ teaspoonful (1.25 mg in 2.5 mL) once daily. 2.4 Children 6 to 11 Months of Age The recommended dose of CLARINEX Oral Solution is 2 mL (1 mg) once daily. 2.5 Adults with Hepatic or Renal Impairment In adult patients with liver or renal impairment, a starting dose of one 5-mg tablet every other day is recommended based on pharmacokinetic data. Dosing recommendation for children with liver or renal impairment cannot be made due to lack of data [see Clinical Pharmacology (12.3) ].
Read the full Dosage and Administration section on DailyMed →
Desloratadine side effects
▾
In studies of adults and adolescents with allergic rhinitis, side effects were mostly similar to placebo. The more common ones were:
Common side effects
- Sore throat (pharyngitis)
- Dry mouth
- Muscle aches (myalgia)
- Tiredness (fatigue)
- Sleepiness (somnolence)
- Painful periods (dysmenorrhea)
- Headache, nausea and dizziness (reported in hives studies)
When to get medical help
- Stop the medicine and get medical help right away for signs of an allergic reaction: rash, itching, hives, swelling, trouble breathing or anaphylaxis.
- Call your doctor about a racing or pounding heartbeat (tachycardia or palpitations).
- Call your doctor about seizures or unusual movements such as tics or muscle spasms (dystonia).
- Call your doctor about signs of liver problems; elevated liver enzymes and hepatitis have been reported.
In people with chronic hives, headache, nausea, dizziness and indigestion were also reported. Seek help for allergic reactions, a fast or pounding heartbeat, seizures, unusual movements or signs of liver problems.
Desloratadine warnings and precautions
▾
The biggest warning is serious allergic reaction, including rash, itching, hives, swelling, trouble breathing and anaphylaxis. Stop desloratadine at once if this happens and ask about other treatments.
- About 6% of people in studies were slow metabolizers, with roughly 6-fold higher drug exposure. Safety looked similar in studies, but a higher risk cannot be ruled out.
- Post-marketing reports include fast heartbeat, palpitations, seizures, movement disorders, hepatitis and raised liver enzymes.
Desloratadine interactions
▾
Some drugs raise desloratadine levels, but studies showed no clinically relevant change in safety.
- Ketoconazole, erythromycin, azithromycin: increased desloratadine levels.
- Fluoxetine: increased desloratadine levels.
- Cimetidine: increased desloratadine levels.
- Food and grapefruit juice: no effect on absorption.
Interactions listed in the FDA-approved label
From the Desloratadine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Inhibitors of Cytochrome P450 3A4 (ketoconazole, erythromycin, azithromycin): Co-administration resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but no clinically relevant changes in the safety profile of desloratadine.
- Fluoxetine: Co-administration resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but no clinically relevant changes in the safety profile of desloratadine.
- Cimetidine: Co-administration resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but no clinically relevant changes in the safety profile of desloratadine.
Read the label’s full interactions text
7 DRUG INTERACTIONS 7.1 Inhibitors of Cytochrome P450 3A4 In controlled clinical studies co-administration of desloratadine with ketoconazole, erythromycin, or azithromycin resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of desloratadine. [See Clinical Pharmacology (12.3).] 7.2 Fluoxetine In controlled clinical studies co-administration of desloratadine with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of desloratadine. [See Clinical Pharmacology (12.3).] 7.3 Cimetidine In controlled clinical studies co-administration of desloratadine with cimetidine, a histamine H2-receptor antagonist, resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of desloratadine. [See Clinical Pharmacology (12.3).]
7.1 Inhibitors of Cytochrome P450 3A4 In controlled clinical studies co-administration of desloratadine with ketoconazole, erythromycin, or azithromycin resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of desloratadine. [See Clinical Pharmacology (12.3).]
7.2 Fluoxetine In controlled clinical studies co-administration of desloratadine with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), resulted in increased plasma concentrations of desloratadine and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of desloratadine.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Desloratadine
▾
- Do not use if you are allergic to desloratadine, its ingredients or loratadine.
- Tell your prescriber about liver or kidney problems; dose changes are recommended for adults.
- Pregnancy: data are too limited to inform risk.
- Breastfeeding: desloratadine passes into breast milk; discuss with your doctor.
- Older adults: dose selection should be cautious.
- Children: the oral solution is not shown safe or effective under 6 months; dosing for children with liver or kidney disease cannot be recommended.
Desloratadine overdose
▾
In studies, sleepiness was reported at higher-than-recommended doses. Healthy volunteers given a much higher dose for 10 days had no clinically relevant adverse events. If an overdose happens, the label advises standard measures to remove unabsorbed drug and symptom-based supportive treatment. Hemodialysis does not remove desloratadine.
What Desloratadine does in the body
▾
Skin tests showed desloratadine's antihistamine effect begins by 1 hour and may last up to 24 hours. The effect did not wear off over 28 days. At a much higher dose than recommended, heart rate rose slightly, but no clinically relevant adverse events were reported.
How your body processes Desloratadine
▾
After a tablet, blood levels peak in about 3 hours. Food and grapefruit juice do not change absorption. The body converts desloratadine to an active metabolite, 3-hydroxydesloratadine, and clears it through urine and feces. The average half-life is about 27 hours, which supports once-daily dosing. Older adults had about 20% higher levels, which was not considered clinically important.
How to store Desloratadine
▾
Desloratadine Tablets: Store at 25° C (77° F); excursions permitted to 15° C - 30° C (59° F - 86° F) Heat sensitive. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Desloratadine
23 supplements and herbal products have documented interactions with Desloratadine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 13
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Desloratadine: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Desloratadine — the kind of thing our pharmacy team would talk through with you at the counter.
What is desloratadine for?
▾
How do I take it?
▾
What side effects should I expect?
▾
When should I call my doctor?
▾
Can I take it with other medicines?
▾
Is it safe in pregnancy or breastfeeding?
▾
Is Desloratadine available over the counter?
▾
When was Desloratadine first available?
▾
Who makes Desloratadine?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Desloratadine on HelloPharmacist
Desloratadine forms and strengths (how it comes)
Desloratadine is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Desloratadine inactive ingredients by manufacturer.
Tablet
How this form is used
- Clarinex tablets are used for seasonal allergic rhinitis in patients 2 years and older, per the Clarinex label.
- Clarinex tablets are used for perennial allergic rhinitis and chronic idiopathic urticaria in patients 6 months and older, per the Clarinex label.
- Desloratadine Tablets are used for seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in patients 12 years and older.
- Clarinex tablets may be taken without regard to meals.
- Desloratadine Tablets are taken once daily, with or without food.
- Desloratadine Tablets: adults with liver or kidney impairment may be started on a less frequent schedule, as directed by their prescriber.
Orally disintegrating tablet
How this form is used
- Desloratadine orally disintegrating tablets are used for seasonal allergic rhinitis in patients 2 years and older, per the label.
- Desloratadine orally disintegrating tablets are used for perennial allergic rhinitis and chronic idiopathic urticaria in patients 6 months and older, per the label.
- Desloratadine orally disintegrating tablets are placed on the tongue and left to dissolve before swallowing, with or without water.
- Take Desloratadine orally disintegrating tablets right after opening the blister.
- Desloratadine orally disintegrating tablets can be taken with or without food.
- Desloratadine orally disintegrating tablets are not recommended for children under 6 years; the label says the syrup is better suited.
Oral solution
How this form is used
- Desloratadine Oral Solution is used for seasonal allergic rhinitis in patients 2 years and older.
- Desloratadine Oral Solution is used for perennial allergic rhinitis and chronic idiopathic urticaria in patients 6 months and older.
- Desloratadine Oral Solution can be taken with or without food.
- Desloratadine Oral Solution should be measured with a measuring dropper or syringe marked for the age-appropriate dose.
- Desloratadine Oral Solution is taken once daily, with the amount based on age.
Desloratadine on the U.S. market: products, makers and brands
How Desloratadine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
10 companies list 15 Desloratadine product records with the FDA, mostly as tablet, orally disintegrating tablet, oral solution; the earliest marketing or approval year on record is 2001. Brand names on the directory include Clarinex, Clarinex Reditabs; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (10) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Desloratadine is used (Medicaid data)
A general measure of how commonly Desloratadine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Desloratadine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Desloratadine prescribed? Of the 1,601 medications we measure, Desloratadine ranks #788 by Medicaid prescriptions — more than 51% of them.
Utilization by Desloratadine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
desloratadine 5 MG Oral Tablet Most dispensed
Summed across the 6 of 44 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349420
desloratadine 5 MG Disintegrating Oral Tablet
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 403841
desloratadine 2.5 MG Disintegrating Oral Tablet
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 577080
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Desloratadine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 8 of 48 listed Desloratadine NDCs with Medicaid activity.
Compare Desloratadine products
A representative set of FDA-listed product records for Desloratadine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Orally disintegrating tablet | ||||
| 2.5 mg | Oral | Dr. Reddy's Laboratories Limited | ANDA | View NDC → |
| 5 mg | Oral | Dr. Reddy's Laboratories Limited | ANDA | View NDC → |
| 💊Oral solution | ||||
| 0.5 mg/mL | Oral | INA Pharmaceutics, Inc. | ANDA | View NDC → |
| 💊Tablet | ||||
| 5 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Bionpharma Inc. | ANDA | View NDC → |
| 5 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Morepen Bio Inc. | ANDA | View NDC → |
| 5 mg | Oral | Natco Pharma USA LLC | ANDA | View NDC → |
| 5 mg | Oral | Organon LLC × 2 listings | NDA | View NDC → |
| 5 mg | Oral | Virtus Pharmaceuticals, LLC | ANDA | View NDC → |
Showing 15 of 15 products — FDA National Drug Code Directory. See every product, package size and price: browse all 15 Desloratadine NDCs →
Desloratadine side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Desloratadine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Desloratadine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Desloratadine FDA approval history
How Desloratadine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Desloratadine recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Desloratadine recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202. Lots: Lot # G201822, exp. date Jan 2024, 100 count G201823, exp. date Jan 2024, 100 count G201824, exp. date Jan 2024, 500 count FDA record D-0221-2024 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 275635 3 dose forms · 4 strengths
-
Dose form (SCDF) Disintegrating Oral Tablet RxCUI 405907In current FDA listings -
Dose form (SCDF) Oral Solution RxCUI 607572In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 607573 -
Dose form (SCDF) Oral Tablet RxCUI 378295In current FDA listingsClinical drug / strength (SCD) 5 MGRxCUI 349420
Look up RxCUI 275635 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Desloratadine supply and shortage status
Whether Desloratadine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Desloratadine costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet, Orally Disintegrating · Oral | 5 mg | $4.78 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Desloratadine brand names
Desloratadine is sold under 2 brand names in the FDA directory — Clarinex, Clarinex Reditabs. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Desloratadine: manufacturers and labelers
10 companies list Desloratadine products with the FDA. By number of product records, the largest are A-S Medication Solutions, Bryant Ranch Prepack, Dr. Reddy's Laboratories Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Desloratadine drug class (RxNorm)
Desloratadine belongs to the Histamine-1 Receptor Antagonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Desloratadine page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Organon LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →